2025
SJR Q2
JCR Q3 · 3,1
204 matched articles
SCIE
Journal detail
Journal of Neuroimmunology
- Publisher
- Elsevier B.V.
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
0165572818728421
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,938
- Quartile Q2
- H-Index 163
- Cites/doc 3,08
- Docs (3y) 448
- Cites (3y) 1.387
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 3,1
- 5Y JIF 2,8
- JCI 0,63
WoS indexes
- SCIE
Subject classification
Categories (SJR)
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,938 | 3,1 | 2,8 | 0,63 | Q3 | 163 |
| 2024 | Q2 | Q3 | 0,903 | 2,5 | 2,6 | 0,62 | Q3 | 159 |
| 2023 | Q2 | Q2 | 0,897 | 2,9 | 3 | 0,61 | Q3 | 159 |
| 2022 | Q2 | Q3 | 0,919 | 3,3 | 3,5 | 0,62 | Q3 | 159 |
| 2021 | Q2 | Q3 | 0,837 | 3,2 | 3,5 | 0,62 | Q3 | 159 |
| 2020 | Q2 | Q3 | 1,06 | 3,5 | 3,4 | 0,75 | Q2 | 159 |
| 2019 | Q2 | Q2 | 1,046 | 3,1 | 2,9 | 0,77 | Q2 | 159 |
| 2018 | — | Q3 | — | 2,8 | 2,8 | 0,74 | Q2 | — |
| 2017 | Q2 | Q3 | 1,083 | 2,7 | 2,6 | 0,72 | Q2 | 159 |
| 2016 | Q1 | Q3 | 1,222 | 2,7 | 2,7 | — | — | 159 |
| 2015 | Q2 | Q3 | 1,196 | 2,5 | 2,7 | — | — | 159 |
| 2014 | Q1 | Q3 | 1,202 | 2,5 | 2,8 | — | — | 159 |
| 2013 | Q1 | Q2 | 1,441 | 2,8 | 3,1 | — | — | 159 |
| 2012 | Q1 | Q2 | 1,277 | 3 | 3 | — | — | 159 |
| 2011 | Q1 | Q2 | 1,271 | 3 | 3 | — | — | 159 |
| 2010 | Q1 | Q2 | 1,383 | 2,9 | 2,9 | — | — | 159 |
| 2009 | — | Q2 | — | 2,8 | 2,8 | — | — | — |
| 2008 | — | Q2 | — | 3,2 | 3,1 | — | — | — |
| 2007 | — | Q2 | — | 2,9 | 3 | — | — | — |
| 2006 | — | Q2 | — | 2,9 | — | — | — | — |
| 2005 | — | Q2 | — | 2,8 | — | — | — | — |
| 2004 | — | Q2 | — | 2,7 | — | — | — | — |
| 2003 | — | Q2 | — | 3,1 | — | — | — | — |
| 2002 | — | Q1 | — | 3,6 | — | — | — | — |
| 2001 | — | Q1 | — | 3,3 | — | — | — | — |
| 2000 | — | Q1 | — | 3,4 | — | — | — | — |
| 1999 | — | Q1 | — | 3,2 | — | — | — | — |
| 1998 | — | Q1 | — | 3,3 | — | — | — | — |
| 1997 | — | Q1 | — | 2,8 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q3 | Q3 | 108/183 |
| 2025 | NEUROSCIENCES | SCIE | Q3 | Q3 | 172/330 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q3 | 122/183 |
| 2024 | NEUROSCIENCES | SCIE | Q3 | Q3 | 192/314 |
| 2023 | IMMUNOLOGY | SCIE | Q3 | Q3 | 108/181 |
| 2023 | NEUROSCIENCES | SCIE | Q2 | Q3 | 144/310 |
| 2022 | IMMUNOLOGY | SCIE | Q3 | Q3 | 106/161 |
| 2022 | NEUROSCIENCES | SCIE | Q3 | Q3 | 144/272 |
| 2021 | IMMUNOLOGY | SCIE | Q4 | Q3 | 123/162 |
| 2021 | NEUROSCIENCES | SCIE | Q3 | Q3 | 180/275 |
| 2020 | IMMUNOLOGY | SCIE | Q3 | Q2 | 105/162 |
| 2020 | NEUROSCIENCES | SCIE | Q3 | Q3 | 151/273 |
| 2019 | IMMUNOLOGY | SCIE | Q3 | Q2 | 92/159 |
| 2019 | NEUROSCIENCES | SCIE | Q2 | Q3 | 126/272 |
| 2018 | IMMUNOLOGY | SCIE | Q3 | Q2 | 95/158 |
| 2018 | NEUROSCIENCES | SCIE | Q3 | Q3 | 138/267 |
| 2017 | IMMUNOLOGY | SCIE | Q3 | Q2 | 94/155 |
| 2017 | NEUROSCIENCES | SCIE | Q3 | Q3 | 156/261 |
| 2016 | IMMUNOLOGY | SCIE | Q3 | — | 88/151 |
| 2016 | NEUROSCIENCES | SCIE | Q3 | — | 136/259 |
| 2015 | IMMUNOLOGY | SCIE | Q3 | — | 89/151 |
| 2015 | NEUROSCIENCES | SCIE | Q3 | — | 145/256 |
| 2014 | IMMUNOLOGY | SCIE | Q3 | — | 89/148 |
| 2014 | NEUROSCIENCES | SCIE | Q3 | — | 156/252 |
| 2013 | IMMUNOLOGY | SCIE | Q2 | — | 70/144 |
| 2013 | NEUROSCIENCES | SCIE | Q3 | — | 137/252 |
| 2012 | IMMUNOLOGY | SCIE | Q2 | — | 63/137 |
| 2012 | NEUROSCIENCES | SCIE | Q2 | — | 116/252 |
| 2011 | IMMUNOLOGY | SCIE | Q3 | — | 72/139 |
| 2011 | NEUROSCIENCES | SCIE | Q2 | — | 114/244 |
| 2010 | IMMUNOLOGY | SCIE | Q2 | — | 65/134 |
| 2010 | NEUROSCIENCES | SCIE | Q2 | — | 114/239 |
| 2009 | IMMUNOLOGY | SCIE | Q2 | — | 61/128 |
| 2009 | NEUROSCIENCES | SCIE | Q2 | — | 113/231 |
| 2008 | IMMUNOLOGY | SCIE | Q2 | — | 49/121 |
| 2008 | NEUROSCIENCES | SCIE | Q2 | — | 83/221 |
| 2007 | IMMUNOLOGY | SCIE | Q2 | — | 50/119 |
| 2007 | NEUROSCIENCES | SCIE | Q2 | — | 81/211 |
| 2006 | IMMUNOLOGY | SCIE | Q2 | — | 48/117 |
| 2006 | NEUROSCIENCES | SCIE | Q2 | — | 78/200 |
| 2005 | IMMUNOLOGY | SCIE | Q2 | — | 44/115 |
| 2005 | NEUROSCIENCES | SCIE | Q2 | — | 76/200 |
| 2004 | IMMUNOLOGY | SCIE | Q2 | — | 41/111 |
| 2004 | NEUROSCIENCES | SCIE | Q2 | — | 75/198 |
| 2003 | IMMUNOLOGY | SCIE | Q2 | — | 31/114 |
| 2003 | NEUROSCIENCES | SCIE | Q2 | — | 55/198 |
| 2002 | IMMUNOLOGY | SCIE | Q1 | — | 26/119 |
| 2002 | NEUROSCIENCES | SCIE | Q1 | — | 41/197 |
| 2001 | IMMUNOLOGY | SCIE | Q1 | — | 26/114 |
| 2001 | NEUROSCIENCES | SCIE | Q1 | — | 48/198 |
| 2000 | IMMUNOLOGY | SCIE | Q1 | — | 20/116 |
| 2000 | NEUROSCIENCES | SCIE | Q1 | — | 47/203 |
| 1999 | IMMUNOLOGY | SCIE | Q1 | — | 17/115 |
| 1999 | NEUROSCIENCES | SCIE | Q1 | — | 44/201 |
| 1998 | IMMUNOLOGY | SCIE | Q1 | — | 18/120 |
| 1998 | NEUROSCIENCES | SCIE | Q1 | — | 38/202 |
| 1997 | IMMUNOLOGY | SCIE | Q1 | — | 23/117 |
| 1997 | NEUROSCIENCES | SCIE | Q2 | — | 42/150 |